FD-1024

N/A

Report date: 2023/10/20 14:21:07
NME

Base Information

Drug NameFD-1024
Drug Alias NameFD-1024FD1024
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsSerine/threonine-protein kinase pim-2 inhibitorsSerine/threonine-protein kinase pim-3 inhibitors
TargetsProto-oncogene serine/threonine-protein kinase Pim-1Serine/threonine-protein kinase pim-2Serine/threonine-protein kinase pim-3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFudan UniversitySD Chem IncABA Chemicals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesABA Chemicals Co LtdSD Chem IncFudan University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A